CSIMarket
 
Relmada Therapeutics Inc  (NASDAQ: RLMD)
 

Relmada Therapeutics Inc's Customers Performance

RLMD



 
RLMD's Source of Revenues

List of RLMD Customers




for the same period Relmada Therapeutics Inc

List of RLMD Customers





Relmada Therapeutics Inc's Comment on Sales, Marketing and Customers



The company serves customers who bill federal programs for products, including those reimbursed under Medicaid and other state programs. Its clients include healthcare practitioners such as physicians (including doctors, dentists, optometrists, podiatrists, and chiropractors), physician assistants, certain advanced practice nurses, and teaching hospitals, all of whom receive payments or transfers of value from prescription drug manufacturers. The markets served encompass federal and state healthcare programs, including Medicare and Medicaid, as well as various state and local jurisdictions with specific regulatory requirements. The company operates within an environment involving pharmaceutical sales and medical representatives.





Relmada Therapeutics Inc’s Comment on Sales, Marketing and Customers


The company serves customers who bill federal programs for products, including those reimbursed under Medicaid and other state programs. Its clients include healthcare practitioners such as physicians (including doctors, dentists, optometrists, podiatrists, and chiropractors), physician assistants, certain advanced practice nurses, and teaching hospitals, all of whom receive payments or transfers of value from prescription drug manufacturers. The markets served encompass federal and state healthcare programs, including Medicare and Medicaid, as well as various state and local jurisdictions with specific regulatory requirements. The company operates within an environment involving pharmaceutical sales and medical representatives.








RLMD's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Relmada Therapeutics Inc 474.23 0.00 -60.90 17
SUBTOTAL 0.00 0.00 0.00 -

Sources: Relmada Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Relmada Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Relmada Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.